DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gradishar WJ, Kaklamani V, Prasad Sahoo T. et al
A double-blind, randomized, placebo-controlled, phase-2b study evaluating the efficacy and safety of sorafenib in combination with paclitaxel as first-line therapy in patients with locally recurrent or metastatic breast cancer.
Cancer Res 2009; 69 (Suppl.): 496 s-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.